Kyongbo Pharmaceutical

Pipeline

Pipeline List

Pipeline Content
Cardiovascular	Clopidogrel, etc
(Development Completion & Release) ~2018 Existing API (40 Items) 2019 Diabetes, etc (1 Items) 2020 Diabetes, etc (3 Items) 2021 Thrombocytopenia, etc (3 Items) 2022 Antithrombotic, etc (6 Items) 2023 Pulmonary Arterial Hypertension, etc (3 Items)

Pipeline Content
Anti-cancer	Imatinlb, etc
(Development Completion & Release) ~2018 Existing API (20 Items) 2019 Breast cancer, etc (5 Items) 2020 Kidney cancer, etc (4 Items) 2021 Prostate cancer, etc (3 Items) 2022 Multiple myeloma (1 Items) 2023 Ovarian cancer, etc (5 Items)

Pipeline Content
Anti-psychotic	Donepezil, etc
(Development Completion & Release) ~2018 Existing API (10 Items) 2019 2020 Epilepsy (1 Items) 2021 2022 Parkinson's disease etc (2 Items) 2023 Alzheimer's etc (3 Items)

Pipeline Content
Anti-virus, Infectious diseases	Entecavir, etc
(Development Completion & Release) ~2018 Existing API (8 Items) 2019 2020 Antifungal (1 Items) 2021 2022 2023

Pipeline Content
Others	Esomeprazole, etc
(Development Completion & Release) ~2018 Existing API (27 Items) 2019 Glaucoma, etc (4 Items) 2020 COPD, etc (4 Items) 2021 Arthritis, etc (7 Items) 2022 Allergies, etc (5 Items) 2023 COPD, etc (3 Items)